FCGR3A and asthma: The percentage of monocytes expressing CCR2 in the intermediate CD14++CD16+ subset was significantly higher only in patients with mild (17 ± 4; p = 0.018) and moderate (17 ± 3; p = 0.003) asthma, not severe asthma, compared to healthy (7%) controls (Fig. 4a).